CLASS II Drug recall · Reported 22 Sep 2021 · FDA Enforcement Report

MIC+Methyl B12 injection Methionine Inositol recalled

Promise Pharmacy is recalling MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1, distributed in Arizona, Colorado, Florida, Illinois, New Jersey. The recall was initiated on 30 Jun 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# 06152021@2, Exp 09/13/2021
Quantity recalled57 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0803-2021
FDA event ID
88662
Recalling firm
Promise Pharmacy, Palm Harbor, FL
Classification
Class II
Status
Terminated
Recall initiated
30 Jun 2021
FDA classified
16 Sep 2021
Reported
22 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Other Reasons

Timeline

30 Jun 2021Recall initiated by company
16 Sep 2021Classified by FDA+78 days
22 Sep 2021Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of processing controls

Product as listed by the FDA

MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS

Where it was distributed

AZ, CO, FL, IL, NJ

ArizonaColoradoFloridaIllinoisNew Jersey

Questions about this recall

Why was it recalled?

Lack of processing controls

Which lots are affected?

Lot# 06152021@2, Exp 09/13/2021

Where was it sold?

AZ, CO, FL, IL, NJ

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Promise Pharmacy

All 53